Table 3.
Association between tissue factor detection and CD4 T-cell immune activation
| CD4 T-cell marker | Percent expression in patients with: | p -value | |
|---|---|---|---|
| Detectable TF | Undetectable TF | ||
| HLADR+ | 43.8 ± 9.8 | 36.2 ± 11.0 | 0.05 |
| TotalCD38+ | 15.2 ± 6.4 | 19.5 ± 9.1 | 0.16 |
| CD38 + HLADR+ | 5.7 ± 2.9 | 5.5 ± 2.8 | 0.85 |
| CD38-HLADR+ | 38.2 ± 8.7 | 30.7 ± 10.4 | 0.04 |
| CD38 + HLADR- | 9.6 ± 3.7 | 14.0 ± 7.4 | 0.01 |
| CD45RA + CCR7- | 8.3 ± 6.3 | 13.3 ± 6.8 | 0.04 |
| CD45RA-CCR7+ | 19.9 ± 5.2 | 19.9 ± 5.2 | 0.99 |
| CD45RA + CCR7+ | 18.4 ± 12.1 | 18.8 ± 10.1 | 0.91 |
| CD45RA-CCR7- | 53.4 ± 15.4 | 48.0 ± 12.3 | 0.23 |
Results reported as mean ± standard deviation.
CD45RA + CCR7-, terminal effectors expressing RA (TEMRA); CD45RA-CCR7+, Central Memory; CD45RA + CCR7+, naïve; CD45RA-CCR7-, effector memory; TF, tissue factor